ASH Voice nke China| Prọfesọ Xian Zhang: Ọrụ dị elu na nchekwa nke Nanobody dabere na mgbochi BCMA CAR-T ọgwụgwọ n'ịgwọ ndị ọrịa nwere nlọghachi azụ ma ọ bụ ọtụtụ Myeloma Refractory.

Emere Nzukọ Kwa Afọ nke 65 nke American Society of Hematology (ASH) site na 9 ruo 12 Disemba 2023, na San Diego, USA. Dị ka ihe omume agụmakwụkwọ kacha elu na hematology nke kachasị n'ụwa, ọ na-adọta puku kwuru puku ndị ọkachamara na ndị ọkà mmụta si n'akụkụ ụwa niile kwa afọ iji kesaa ọganihu hematology kacha dị egwu yana data ụlọ ọgwụ na-akụda ala. Na ASH Congress nke afọ a, a họpụtara ọmụmụ Prọfesọ Xian Zhang nke ụlọ ọgwụ Lu Dao Pei maka nkwupụta ọnụ (Abstract No. 2107), bụ nke nyochara oke arụmọrụ na nchekwa nke nanobody dabeere na BCMA CAR-T therapy na-agwọ ndị ọrịa nwere nsogbu. otutu myeloma na-agbaghachi azụ ma ọ bụ refractory.